Steroids in susceptible individuals can cause a clinical condition similar to primary open-
angle glaucoma. Five percent of the population are high steroid responders and develop an …

The use of intravitreal (IVT) corticosteroids for treatment of posterior segment diseases has
increased significantly over the last decade. A commonly recognized complication of IVT …

PURPOSE: To assess the efficacy and safety of intraocular injections of 0.3 mg or 0.5 mg
ranibizumab in patients with macular edema after central retinal vein occlusion (CRVO) …

Elevation of intraocular pressure (IOP) due to therapeutic use of glucocorticoids is called
steroid-induced ocular hypertension (SIOH); this can lead to steroid-induced glaucoma …

Aims: The aim of the study was to evaluate functional and anatomical changes after
intravitreal bevacizumab (Avastin®) in eyes with persistent macular oedema secondary to …

Objective: To evaluate efficacy and safety of intravitreal bevacizumab (Avastin) in eyes with
macular oedema secondary to central retinal vein occlusion (CRVO) or branch retinal vein …

Purpose: To report the incidence of acute endophthalmitis as a complication of intravitreal
bevacizumab (Avastin)(IVB) injection in a tertiary vitreoretinal group practice. Methods: A …

Macular edema, a condition usually associated with an underlying disease process, is a
common cause of severe visual loss. There have been a variety of approaches to the …

Purpose: To present the finding of tiny silicone oil droplets in 15 eyes of 15 patients after
intravitreal injections of an anti–vascular endothelial growth factor agent or triamcinolone …

Background Macular edema is the main reason for decreased visual acuity (VA) in early
retinal vein occlusion (RVO). Bevacizumab (Avastin, Genentech) is an anti-VEGF substance …